Evidence map›Paper›PMID 31569142›Full record

ArticlePain2020

Upregulation of cortical GABAA receptor concentration in fibromyalgia.

Florence B Pomares, Steve Roy, Thomas Funck, Natasha A Feier, Alexander Thiel, Mary-Ann Fitzcharles, Petra Schweinhardt

Open access · hybridAbstract read
In one paragraph

Article in Pain, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 3 pooled it
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 3 syntheses or guidelines pooled it, 51 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Functional Magnetic Resonance Imaging Signal Variability Is Associated With Neuromodulation in Fibromyalgia.Neuromodulation : journal of the International Neuromodulation Society · 2023
    Trial
  7. Trial
  8. Review
  9. Article
  10. Article
  11. Fibromyalgia in the Era of Brain PET/CT Imaging.Journal of clinical medicine · 2025
    Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Florence B PomaresAlan Edwards Centre for Research on Pain, McGill University, Montreal, QC, Canada.
Steve RoyAlan Edwards Centre for Research on Pain, McGill University, Montreal, QC, Canada.
Thomas FunckMcConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University, Montreal, QC, Canada.
Natasha A FeierAlan Edwards Centre for Research on Pain, McGill University, Montreal, QC, Canada.
Alexander ThielDepartment of Neurology and Neurosurgery, McGill University, Montreal, QC, Canada.
Mary-Ann FitzcharlesDivision of Rheumatology, McGill University Health Centre, Montreal, QC, Canada.
Petra SchweinhardtAlan Edwards Centre for Research on Pain, McGill University, Montreal, QC, Canada.
McGill University · CAMcGill University Health Centre · CAMontreal Neurological Institute and Hospital · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An imbalance between excitatory and inhibitory neurotransmission has been linked to fibromyalgia (FM). Magnetic resonance spectroscopy has shown increased levels of glutamate in the insula and posterior cingulate cortex in FM as well as reduced insular levels of gamma-aminobutyric acid (GABA). Both of these changes have been associated with increased pain sensitivity. However, it is not clear whether excitatory and/or inhibitory neurotransmission is altered across the brain. Therefore, the aim of this study was to quantify GABAA receptor concentration on the whole brain level in FM to investigate a potential dysregulation of the GABAergic system. Fifty-one postmenopausal women (26 FM, 25 matched controls) underwent assessments of pain sensitivity, attention and memory, psychological status and function, as well as positron emission tomography imaging using a tracer for GABAA receptors, [F]flumazenil. Patients showed increased pain sensitivity, impaired immediate memory, and increased cortical GABAA receptor concentration in the attention and default-mode networks. No decrease of GABAA receptor concentration was observed. Across the 2 groups, GABAA receptor concentration correlated positively with functional scores and current pain in areas overlapping with regions of increased GABAA receptor concentration. This study shows increased GABAA receptor concentration in FM, associated with pain symptoms and impaired function. The changes were widespread and not restricted to pain-processing regions. These findings suggest that the GABAergic system is altered, possibly indicating an imbalance between excitatory and inhibitory neurotransmission. Future studies should try to understand the nature of the dysregulation of the GABAergic system in FM and in other pain syndromes.

Indexed as

Up-RegulationAgedAttentionCerebral CortexFemaleFibromyalgiaHumansMagnetic Resonance ImagingMental RecallMiddle AgedNeuropsychological TestsPain MeasurementPain ThresholdPositron-Emission TomographyReceptors, GABA-AReceptors, GABA-A

Identifiers

PMID31569142
PMCPMC6940028
OpenAlexW2978689864

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.